Alpha 2.0
Login Register
» Authors » Franck Drouet

Franck Drouet

Explore the profile of Franck Drouet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 26
Followers 0
Related Specialties
Oncology
General Medicine
Dentistry
Top 10 Co-Authors
Veronique Vendrely
Elodie Menager-Tabourel
Laurent Quero
Nabil Baba-Hamed
Pauline Regnault
Gilles Crehange
Olivia Diaz
Angelique Saint
Karine Le Malicot
Eleonor Rivin Del Campo
Published In
Med Sci (Paris)
Phys Med
Br J Cancer
Eur J Dermatol
Radiother Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE
Gouriou C, Lemanski C, Pommier P, Le Malicot K, Saint A, Rivin Del Campo E, et al.
Br J Cancer . 2024 Jan; 130(5):769-776. PMID: 38184691
Background: Standard care for non-metastatic squamous cell carcinoma of the anus (SCCA) is chemoradiotherapy, data about elderly patients are scarce. Methods: All consecutive patients treated for non-metastatic SCCA from the...
2.
Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy
Metz R, Rauscher A, Vaugier L, Supiot S, Drouet F, Campion L, et al.
Cancers (Basel) . 2023 Mar; 15(6). PMID: 36980784
Background: In hormone-sensitive oligorecurrent prostate cancer (PC), the literature showed [68Ga]Ga-PSMA (PSMA) and [18F]F-choline (FCH) PET/CT can successfully guide metastasis-directed therapies (MDT). This observational retrospective study aimed to explore, in...
3.
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
Vendrely V, Lemanski C, Pommier P, Le Malicot K, Saint A, Rivin Del Campo E, et al.
Radiother Oncol . 2023 Feb; 183:109542. PMID: 36813175
Introduction: International guidelines regarding the treatment of squamous cell carcinoma of the anus (SCCA) recommend intensity-modulated radiotherapy (IMRT) combined with mitomycin-based chemotherapy (CT). The French FFCD-ANABASE cohort aimed at evaluating...
4.
Implementation of volumetric-modulated arc therapy for locally advanced breast cancer patients: Dosimetric comparison with deliverability consideration of planning techniques and predictions of patient-specific QA results via supervised machine...
Noblet C, Duthy M, Coste F, Saliou M, Samain B, Drouet F, et al.
Phys Med . 2022 Feb; 96:18-31. PMID: 35202917
Purpose: The aim of this study was to implement a clinically deliverable VMAT planning technique dedicated to advanced breast cancer, and to predict failed QA using a machine learning (ML)...
5.
Cervical node of unknown primary: patterns of care and factors influencing the choice of clinical target volumes
Troussier I, Bensadoun R, Chamorey E, Lapeyre M, Baujat B, Leysalle A, et al.
Oral Oncol . 2014 Mar; 50(5):e25-6. PMID: 24630259
No abstract available.
6.
Severe radiotherapy-induced extracutaneous toxicity under vemurafenib
Peuvrel L, Ruellan A, Thillays F, Quereux G, Brocard A, Saint-Jean M, et al.
Eur J Dermatol . 2013 Nov; 23(6):879-81. PMID: 24192487
Background: Vemurafenib is a BRAF inhibitor indicated for the treatment of metastatic melanoma. We report the two first cases of severe and prolonged radiotherapy-induced visceral toxicity in patients treated concomitantly...
7.
[Radiotherapy and atherosclerosis: current data and issues]
Gaugler M, Drouet F, Krempf M
Med Sci (Paris) . 2010 Sep; 26(8-9):740-6. PMID: 20819712
The continuous optimization of cancer treatment with radiotherapy raises the problem of long-term issue of patients treated and cured by ionizing radiation, with the possible occurrence of second cancers or...